نتایج جستجو برای: peginterferon alfa

تعداد نتایج: 19203  

Journal: :Türkiye Fiziksel Tip ve Rehabilitasyon Dergisi 2014

2010
Hossein Khedmat Saeed Taheri

I their meta-analysis of the efficacy of peginterferon alfa-2a (PEG-IFN-α2a) or alfa2b (PEG-IFN-α2b) and ribavirin for the treatment of hepatitis C virus (HCV), Alavian et al. (1), analyzing pooled data from 7 studies, conclude that PEG-IFNα2a (with similar safety) is more effective than PEGIFN-α2b. While PEG-IFN alfa-2b with ribavirin is generally considered as the treatment of choice for chro...

Journal: :Hepatology 2007
Robert J Fontana Linas A Bieliauskas Karen L Lindsay Carla Back-Madruga Elizabeth C Wright Kristin K Snow Anna S F Lok Ziad Kronfol Latha Padmanabhan

UNLABELLED Treatment of chronic hepatitis C with pegylated interferon (peginterferon) and ribavirin can cause or exacerbate depression but its effects on cognitive function are largely unknown. The aim of this study was to determine whether treatment with peginterferon and ribavirin adversely impacts cognitive function in patients with chronic hepatitis C. Prior nonresponders to interferon were...

Journal: :The New England journal of medicine 2009
John G McHutchison Gregory T Everson Stuart C Gordon Ira M Jacobson Mark Sulkowski Robert Kauffman Lindsay McNair John Alam Andrew J Muir

BACKGROUND Current therapy for chronic hepatitis C virus (HCV) infection is effective in less than 50% of patients infected with HCV genotype 1. Telaprevir, a protease inhibitor specific to the HCV nonstructural 3/4A serine protease, rapidly reduced HCV RNA levels in early studies. METHODS We randomly assigned patients infected with HCV genotype 1 to one of three telaprevir groups or to the c...

2015
Chen-Hua Liu Chung-Feng Huang Chun-Jen Liu Chia-Yen Dai Jee-Fu Huang Jou-Wei Lin Cheng-Chao Liang Sheng-Shun Yang Chih-Lin Lin Tung-Hung Su Hung-Chih Yang Pei-Jer Chen Ding-Shinn Chen Wan-Long Chuang Jia-Horng Kao Ming-Lung Yu

The impact of ribavirin (RBV) dosage on sustained virologic response (SVR) rates remains elusive in hepatitis C virus genotype 2 (HCV-2) rapid responders receiving 16 weeks of peginterferon (Peg-IFN) plus RBV. Treatment-naïve HCV-2 patients with rapid virologic response (RVR) received Peg-IFN alfa-2a 180 μg/week plus weight-based RBV (1,000 or 1,200 mg/day; cut-off body weight: 75 kg) for 6 wee...

2015
Yonghong Zhu

In 1989, scientists at Chiron (acquired by Novartis in 2006), in collaboration with a CDC researcher, first reported the molecular cloning of hepatitis C virus (HCV) genome from serum samples of patients diagnosed with Non-A Non-B viral hepatitis [1]. After the discovery of HCV, tremendous progress has been made toward better understanding the virus itself and its associated chronic hepatitis C...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید